Spread of Klebsiella Pneumoniae Carbapenemase-2-Producing Klebsiella Pneumoniae Clones in Asia

References

• Liu SW , ChangHJ , ChiaJH , KuoAJ , WuTL , LeeMH . Outcomes and characteristics of ertapenem-nonsusceptible Klebsiella pneumoniae bacteremia at a university hospital in Northern Taiwan: a matched case–control study . J. Microbiol. Immunol. Infect.   45 ( 2 ), 113 – 119 ( 2012 ).
   PubMedGoogle Scholar
• Qureshi ZA , PatersonDL , PotoskiBAet al. Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens . Antimicrob. Agents. Chemother.   56 ( 4 ), 2108 – 2113 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Tumbarello M , VialeP , ViscoliCet al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumonia carbapenemase-producing K. pneumoniae: importance of combination therapy . Clin. Infect. Dis.   55 ( 7 ), 943 – 950 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Jean SS , LeeWS , HsuehPR . Nationwide spread of Klebsiella pneumoniae carbapenemase-2-producing K. pneumoniae sequence type 11 in Taiwan . J. Microbiol. Immunol. Infect.   46 ( 5 ), 317 – 319 ( 2013 ).
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention of Taiwan. The monitor report, from Taiwanese Nosocomial Infection Surveillance System, in the third quarter of 2012 (written in Chinese). www.taichung.gov.tw/public/Data/31411292471.pdf
   Google Scholar
• Qi Y , WeiZ , JiS , DuX , ShenP , YuY . ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China . J. Antimicrob. Chemother.   66 ( 2 ), 307 – 312 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Ma L , LuPL , SiuLK , HsiehMH . Molecular typing and resistance mechanisms of imipenem-non-susceptible Klebsiella pneumoniae in Taiwan: results from the Taiwan surveillance of antibiotic resistance (TSAR) study, 2002–2009 . J. Med. Microbiol.   62 ( 1 ), 101 – 107 ( 2013 ).
   PubMedGoogle Scholar
• Hung KH , YanJJ , LuJJ , ChenHM , WuJJ . Characterization of the modified Hodge test-positive isolates of Enterobacteriaceae in Taiwan . J. Microbiol. Immunol. Infect.   46 ( 1 ), 35 – 40 ( 2013 ).
   PubMedGoogle Scholar
• Chung KP , TsengSP , HuangYT , TsaiTH , TengLJ , HsuehPR . Arrival of Klebsiella pneumoniae carbapenemase (KPC)-2 in Taiwan . J. Antimicrob. Chemother.   66 ( 5 ), 1182 – 1184 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Lee CM , LiaoCH , LeeWSet al. Outbreak of Klebsiella pneumonia carbapenemase-2-producing K. pneumonia sequence type 11 in Taiwan in 2011 . Antimicrob. Agents. Chemother.   56 ( 10 ), 5016 – 5022 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Chiu SK , WuTL , ChuangYCet al. National surveillance study on carbapenem non-susceptible Klebsiella pneumoniae in Taiwan: the emergence and rapid dissemination of KPC-2 carbapenemase . PLoS ONE   8 ( 7 ), e69428 – e69434 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Balm MN , NganG , JureenR , LinRT , TeoJ . Molecular characterization of newly emerged blaKPC-2-producing Klebsiella pneumoniae in Singapore . J. Clin. Microbiol.   50 ( 2 ), 475 – 476 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Koyano S , SaitoR , NagaiRet al. Molecular characterization of carbapenemase-producing clinical isolates of Enterobacteriaceae in a teaching hospital, Japan . J. Med. Microbiol.   62 ( 3 ), 446 – 450 ( 2013 ).
   PubMedGoogle Scholar
• Yoo JS , KimHM , YooJIet al. Detection of clonal KPC-2-producing Klebsiella pneumonia ST258 in Korea during nationwide surveillance in 2011 . J. Med. Microbiol.   62 ( 9 ), 1338 – 1342 ( 2013 ).
   PubMedGoogle Scholar
• Zowawi HM , BalkhyHH , WalshTR , PatersonDL . β-lactamase production in key Gram-negative pathogen isolates from the Arabian Peninsula . Clin. Microbiol. Rev.   26 ( 3 ), 361 – 380 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Chen YT ,  LinJC ,  FungCPet al. KPC-2-encoding plasmids from Escherichia coli and Klebsiella pneumoniae in Taiwan .  J. Antimicrob. Chemother.  doi:10.1093/jac/dkt409 ( 2013 ) (Epub ahead of print).
   Google Scholar
• Huang SR , LiuMF , LinCF , ShiZY . Molecular surveillance and clinical outcomes of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae infections . J. Microbiol. Immunol. Infect. doi:10.1016/j.jmii.08.029 ( 2012 ) (Epub ahead of print).
   Google Scholar
• Spanu T , DeAngelis G , CiprianiMet al. In vivo emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae and Escherichia coli . Antimicrob. Agents. Chemother.   56 ( 8 ), 4516 – 4518 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Lee J , PatelG , HuprikarS , CalfeeDP , JenkinsSG . Decreased susceptibility to polymyxin B during treatment for carbapenem-resistant Klebsiella pneumoniae infection . J. Clin. Microbiol.   47 ( 5 ), 1611 – 1612 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Kuti JL , DandekarPK , NightingaleCH , NicolauDP . Use of Monte Carlo simulation to design an optimized pharmacodynamics dosing strategy for meropenem . J. Clin. Pharmacol.   43 ( 10 ), 1116 – 1123 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Lee GC , BurgessDS . Treatment of Klebsiella pneumoniae carbapenemase (KPC) infections: a review of published case series and case reports . Ann. Clin. Microbiol. Antimicrob.   11 , 32 – 40 ( 2012 ).
   PubMed Web of Science ®Google Scholar